Related references
Note: Only part of the references are listed.Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O-6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs
Wynand P. Roos et al.
DNA REPAIR (2009)
Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
R. Dummer et al.
ANNALS OF ONCOLOGY (2008)
Common variants of DNA repair genes and malignant melanoma
T. Debniak et al.
EUROPEAN JOURNAL OF CANCER (2008)
Phase II study of extended-dose temozolomide in patients with melanoma
Petra Rietschel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma:: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K. Spieth et al.
ANNALS OF ONCOLOGY (2008)
Management of metastatic melanoma
Hussein A. Tawbi et al.
SEMINARS IN ONCOLOGY (2007)
Temozolomide induces senescence but not apoptosis in human melanoma cells
N. M. Mhaidat et al.
BRITISH JOURNAL OF CANCER (2007)
MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents
Bernd Kaina et al.
DNA REPAIR (2007)
Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma
Malcolm Ranson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Promoter hypermethylation of the O-6-methylguanine DNA methyltransferase gene and microsatellite instability in metastatic melanoma
Maija R. J. Kohonen-Corish et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: A randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group
R Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma
S Ma et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
